On-Demand CME Videos
PEDS24: Paving the Way for Non-Steroidal Topicals for Pediatric Patients With Atopic Dermatitis and Plaque Psoriasis: An Online Activity
About
PEDS24: Paving the Way for Non-Steroidal Topicals for Pediatric Patients With Atopic Dermatitis and Plaque Psoriasis: An Online Activity
This activity is supported by educational grants from Arcutis Biotherapeutics, Incyte, Dermavant and Incyte.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
December 19, 2024
December 21, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Identify the burden of atopic dermatitis (AD) and plaque psoriasis on pediatric patients’ quality of life
Review the latest clinical evidence on approved and emerging non-steroidal topicals to manage AD and plaque psoriasis in pediatric patients
Outline practical and communication strategies for managing pediatric patients with AD and plaque psoriasis
Intended Audience
Faculty
Adelaide Hebert, MD
Professor of Dermatology and Pediatrics
UTHealth McGovern Medical School
Houston, TX
Lisa Swanson, MD
Pediatric Dermatologist
Ada West Dermatology
Boise, ID
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: Pfizer, Arcutis, Lilly, AbbVie
Consultant: Pfizer, Arcutis, Almirall, Biofrontera, Galderma, Or
Speakers’ Bureau or Honoraria: Pfizer, Arcuits, Almirall, Incyte, Sun
Consultant: Janssen, Lilly, Ortho Dermatologics, Sanofi-Regeneron, Pfizer, LEO, Novan, Arcutis
Speakers’ Bureau or Honoraria: Ortho Dermatologics, Pfizer, Amgen, Sanofi-Regeneron, Almirall, Janssen, Lilly, Novartis, Abbvie, Incyte
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.